Axogen's Q4 earnings report showing better-than-expected losses and sales growth is likely to be viewed positively by investors. The significant beat on both EPS and sales estimates, coupled with an 18.51% year-over-year sales increase, suggests strong operational performance and market demand for Axogen's offerings. Despite the increase in losses compared to the previous year, the overall positive earnings report could lead to short-term bullish sentiment among investors.